Trial
NCT00939549
High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Relapsing Remitting Multiple Sclerosis
Intervention
Cyclophosphamide/Glatiramer acetate
Why stopped
Study revised to retrospective chart review
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-26